Medical Materiel/Medical Biological Defense Equipment - Eng Dev
Abstract
This Program Element (PE) funds advanced development of medical materiel within the System Demonstration and Low Rate Initial Production portions of the acquisition life cycle using Budget Activity 6.5 (System Development and Demonstration) funding. It supports products successfully developed in the Systems Integration portion of the Systems Development and Demonstration phases through completion of the Milestone C Decision Review. Commercially-off-the-shelf (COTS) medical products are also tested and evaluated for military use, when available. This PE primarily includes pivotal (conclusive) human clinical trials necessary for licensure by the Food and Drug Administration (FDA). Projects in this PE include the following: Project 832 funds the engineering and manufacturing development of medical products for enhanced combat casualty care and follow-on care, including rehabilitation. Mature COTS medical products are also evaluated for military use. Consideration will also be given to reduce the medical sustainment footprint through smaller weight and cube volume, or equipment independence from supporting materiel. Products from this project will normally transition to OPA Funds. Project 849 funds development of candidate medical countermeasures for military relevant infectious diseases. These products fall in four major areas: vaccines, drugs, diagnostic kits/devices, and insect control measures to limit exposure and disease transmission. FDA approval is a mandatory obligation for all military products placed into the hands of medical providers or service members for human use. Products from this project will normally transition to DoD Health Programs or OPA funds. These Projects are managed by United States (U.S.) Army Medical Materiel Development Activity (USAMMDA) of the U.S. Army Medical Research and Development Command.
Document Details
- Document Type
- R2 Budgetary Justification
- Publication Date
- Oct 01, 2024
- Source ID
- 0604807A_5_2040_PB_2024
- Change Summary Explanation
- Decreased funding to support higher Army priorities.
- Service Agency Name
- Army
Entities
Organizations
- United States Army
Related Documents
- Child Project: Field Medical Systems Engineering Development
- Child Accomplishment: Field Medical Systems Engineering Development - Medical Readiness
- Child Accomplishment: Field Medical Systems Engineering Development - Battlefield Care and Return to Fight
- Child Accomplishment: SBIR/STTR
- Child Cost Item: b1deb1f635f74d0f53cea0aa725aff85
- Child Cost Item: bba0a6aa0864697b6ea9bc707fcb385f
- Child Cost Item: 8663db20212cdcee9d676cf8cbda60ed
- Child Cost Item: 249ca003e927a85150ae8fd0951c8be3
- Child Cost Item: 9897e9361952b26b325238e240fc4eeb
- Child Cost Item: a01b5fa842537d34ff223aca7f6bbc48
- Child Cost Item: 691c265ac290178cca2cdb00f927126e
- Child Cost Item: 1e44daf3bee7c287eb363942a49afe00
- Child Cost Item: 552226524c6e0531f1575278510cc27c
- Child Cost Item: b9f32e0ef942e945c88aba0d22d5a680
- Child Cost Item: 1e575504d934320b3ad80e4d78728c55
- Child Cost Item: 197eef0b5e86fc087dfe1d7c5a5a1be9
- Child Cost Item: b03ba29ac0ab91d24e65a75eb702f012
- Child Project: Infec Dis Drug/Vacc Ed
- Child Accomplishment: Infectious Disease Drug and Vaccine Engineering Development - Medical Readiness
- Child Accomplishment: Infectious Disease Drug and Vaccine Engineering Development - Battlefield Care and Return to Fight
- Child Cost Item: e125ecf2a5bac3c08194505d5c5cfa32
- Child Cost Item: 3300e1f323bc58ba61046fd7d16030ed
- Child Cost Item: 06ae299a16db8760f12bc7bf856ec13f
- Child Cost Item: cb4db5b086d6f37b3a81693566f8f553
- Child Cost Item: d63082bcf3d1b7853f12f5af3263baee
- Child Cost Item: 4b39b3cd1cbbf67417738356c1289ba9
- Child Cost Item: c81099c2e1a5b0aed9d4dc250362a693
- Child Cost Item: 53fe6193bfbada78adc1093aeeefd875
- Child Cost Item: 703c29685ceb612389a1004ee0297532